Teva, the world's largest generic drugmaker, is cutting 14,000 workers - Los Angeles Times
Cramer: Avoid This Drug Stock
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Teva seeks blockbuster drug to succeed Copaxone - Globes
Generics distributor Anda, Inc. has a new owner: Teva Pharma
TEVA stock on watch after EU approval for biosimilar to Roche's Lucentis (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical to ax 14,000 workers worldwide - CBS News
FDA Approves Generic Version Of Teva's Blockbuster Drug - Drug Discovery and Development
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
Report: Teva Suffers Migraine Over Express Scripts Drug Exclusion - Pharmaceutical Processing World
A determined FDA takes down Teva's blockbuster | Evaluate
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
Sex, drugs, and sharing trade secrets
Teva plans to sell Irvine drug plant – Orange County Register
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Roche's Ocrevus achieves blockbuster status - Pharmaceutical Technology
Teva Pharmaceuticals considers laying-off 10,000 workers - The Jerusalem Post
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent
Teva agrees to buy Allergan's generics distribution unit
Teva to cut 14,000 jobs | Business | Chemistry World
Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
Teva Pharmaceutical Stock Could Double | Barron's
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
